These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27852542)

  • 1. Factors associated with elevated serum chromogranin A levels in patients with autoimmune gastritis.
    Kalkan Ç; Karakaya F; Soykan İ
    Turk J Gastroenterol; 2016 Nov; 27(6):515-520. PubMed ID: 27852542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromogranin A as a useful neuroendocrine marker in patients with autoimmune Addison's disease.
    El Ali Z; Fichna M; Piniewska J; Kosowicz J; Grzymisławski M
    J Endocrinol Invest; 2010 Mar; 33(3):186-91. PubMed ID: 19794299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum chromogranin A level continuously rises with the progression of type 1 diabetes, and indicates the presence of both enterochromaffin-like cell hyperplasia and autoimmune gastritis.
    Herold Z; Herold M; Nagy P; Patocs A; Doleschall M; Somogyi A
    J Diabetes Investig; 2020 Jul; 11(4):865-873. PubMed ID: 31883432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on histogenesis of enterochromaffin-like carcinoid in autoimmune atrophic gastritis associated with pernicious anemia].
    Macukanović-Golubović L; Katić V; Rancić G; Milenović M; Marjanović G; Golubović Z
    Vojnosanit Pregl; 2007 Aug; 64(8):543-8. PubMed ID: 17874722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma chromogranin A in patients with autoimmune chronic atrophic gastritis, enterochromaffin-like cell lesions and gastric carcinoids.
    Peracchi M; Gebbia C; Basilisco G; Quatrini M; Tarantino C; Vescarelli C; Massironi S; Conte D
    Eur J Endocrinol; 2005 Mar; 152(3):443-8. PubMed ID: 15757862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are patients with autoimmune thyroid disease and autoimmune gastritis at risk of gastric neuroendocrine neoplasms type 1?
    Alexandraki KI; Nikolaou A; Thomas D; Syriou V; Korkolopoulou P; Sougioultzis S; Kaltsas G
    Clin Endocrinol (Oxf); 2014 May; 80(5):685-90. PubMed ID: 24118101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of silent gastric carcinoid in a type 1 diabetic patient with primer hypothyreosis].
    Somogyi A; Ruzicska E; Varga T; Rácz K; Nagy G
    Orv Hetil; 2007 Sep; 148(35):1667-71. PubMed ID: 17720674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal chromogranin A and gastrin concentrations in circulation correlate to endocrine cell proliferation in type-A gastritis.
    Borch K; Stridsberg M; Burman P; Rehfeld JF
    Scand J Gastroenterol; 1997 Mar; 32(3):198-202. PubMed ID: 9085454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy.
    Sanduleanu S; De Bruïne A; Stridsberg M; Jonkers D; Biemond I; Hameeteman W; Lundqvist G; Stockbrügger RW
    Eur J Clin Invest; 2001 Sep; 31(9):802-11. PubMed ID: 11589723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyautoimmunity in autoimmune gastritis.
    Kalkan Ç; Soykan I
    Eur J Intern Med; 2016 Jun; 31():79-83. PubMed ID: 27085391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meal test improves the specificity of chromogranin A as a marker of neuroendocrine neoplasia.
    Jianu CS; Fossmark R; Syversen U; Hauso Ø; Waldum HL
    Tumour Biol; 2010 Oct; 31(5):373-80. PubMed ID: 20480408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year follow-up of patients treated for 1 year with octreotide long-acting release for enterochromaffin-like cell carcinoids.
    Jianu CS; Fossmark R; Syversen U; Hauso Ø; Fykse V; Waldum HL
    Scand J Gastroenterol; 2011 Apr; 46(4):456-63. PubMed ID: 21133821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical profiles, endoscopic and laboratory features and associated factors in patients with autoimmune gastritis.
    Soykan I; Yakut M; Keskin O; Bektaş M
    Digestion; 2012; 86(1):20-6. PubMed ID: 22710370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune gastritis presenting as iron deficiency anemia in childhood.
    Gonçalves C; Oliveira ME; Palha AM; Ferrão A; Morais A; Lopes AI
    World J Gastroenterol; 2014 Nov; 20(42):15780-6. PubMed ID: 25400463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune gastritis. A clinicopathologic study of 25 cases.
    Chlumská A; Boudová L; Benes Z; Zámecník M
    Cesk Patol; 2005 Oct; 41(4):137-42. PubMed ID: 16382988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of BCL-2 oncoprotein in the development of enterochromaffin-like cell gastric carcinoids.
    Azzoni C; Doglioni C; Viale G; Delle Fave G; De Boni M; Caruana P; Ferraro G; Bordi C
    Am J Surg Pathol; 1996 Apr; 20(4):433-41. PubMed ID: 8604810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypergastrinemia and gastric enterochromaffin-like cells.
    Bordi C; D'Adda T; Azzoni C; Pilato FP; Caruana P
    Am J Surg Pathol; 1995; 19 Suppl 1():S8-19. PubMed ID: 7762739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine tumor markers and enterochromaffin-like cell hyper/dysplasia in type 1 diabetes.
    De Block CE; Colpin G; Thielemans K; Coopmans W; Bogers JJ; Pelckmans PA; Van Marck EA; Van Hoof V; Martin M; De Leeuw IH; Bouillon R; Van Gaal LF
    Diabetes Care; 2004 Jun; 27(6):1387-93. PubMed ID: 15161793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histologic changes in type A chronic atrophic gastritis indicating increased risk of neuroendocrine tumor development: the predictive role of dysplastic and severely hyperplastic enterochromaffin-like cell lesions.
    Vanoli A; La Rosa S; Luinetti O; Klersy C; Manca R; Alvisi C; Rossi S; Trespi E; Zangrandi A; Sessa F; Capella C; Solcia E
    Hum Pathol; 2013 Sep; 44(9):1827-37. PubMed ID: 23642738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxyntic gastric atrophy in Helicobacter pylori gastritis is distinct from autoimmune gastritis.
    Venerito M; Varbanova M; Röhl FW; Reinhold D; Frauenschläger K; Jechorek D; Weigt J; Link A; Malfertheiner P
    J Clin Pathol; 2016 Aug; 69(8):677-85. PubMed ID: 26729016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.